help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brichard, S. M.
Right arrow Articles by Jeanrenaud, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brichard, S. M.
Right arrow Articles by Jeanrenaud, B.

Endocrinology, Vol 131, 311-317, Copyright © 1992 by Endocrine Society


ARTICLES

Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant fa/fa rats without modifying glucose transporter expression

SM Brichard, F Assimacopoulos-Jeannet and B Jeanrenaud
Laboratories of Metabolic Research, Faculty of Medicine, University of Geneva, Switzerland.

The present study examined the effects of chronic treatment with vanadate on in vivo insulin-stimulated glucose uptake by various tissues of obese and insulin-resistant fa/fa rats. It further determined whether the substantial improvement induced by vanadate administration was associated with altered expression of the insulin- responsive glucose transporter (GLUT4). Since oral Na3VO4 caused decreases in food intake and body weight, vanadate-treated fa/fa rats were compared with controls, fed ad libitum, and pair-fed rats. The animals in the three groups were submitted to hyperinsulinemic clamps combined with the 2-deoxyglucose method. At similar levels of imposed hyperinsulinemia, the glucose infusion rate (milligrams per kg.min-1) required to maintain euglycemia, extremely low in controls (0.8 +/- 0.3) and pair-fed rats (1.2 +/- 0.6), was strikingly improved in vanadate-treated rats (9.5 +/- 0.3). Correspondingly, the insulin- mediated glucose utilization indices were 2- to 3-fold higher in all types of muscle in treated rats: hindlimb skeletal muscle, diaphragm, and heart. Glucose utilization remained unaffected in white adipose tissue and jejunum, whereas it was increased by mere food restriction in brown adipose tissue of pair-fed rats. The amounts of GLUT4 and GLUT4 mRNA were then measured in the insulin-sensitive tissues of the three groups of animals. Vanadate treatment induced no change in GLUT4 mRNA or GLUT4 protein levels in any of the examined tissues. It even prevented the rise in GLUT4 protein expression caused by calorie restriction in brown adipose tissue of pair-fed rats. In conclusion, chronic administration of vanadate markedly increases the insulin- mediated glucose uptake in muscle of insulin-resistant fa/fa rats without altering GLUT4 number. A functional improvement of glucose transporters due to more efficient translocation and/or increased intrinsic activity or changes in the insulin signaling pathway is, thus, likely to play a major role in the beneficial effects of vanadate.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre
Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1055 - E1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Asante-Appiah and B. P. Kennedy
Protein tyrosine phosphatases: the quest for negative regulators of insulin action
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E663 - E670.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Barbagallo, L. J. Dominguez, and L. M. Resnick
Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium
Hypertension, September 1, 2001; 38(3): 701 - 704.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter
L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO
J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Sekar, S. Qian, and Y. Shechter
Vanadate Elevates Lipogenicity of Starved Rat Adipose Tissue: Mechanism of Action
Endocrinology, May 1, 1998; 139(5): 2514 - 2518.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus
Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)
J. Biol. Chem., September 14, 2001; 276(38): 35589 - 35598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society